IntraOp Announces First Randomized Phase II Selection Trial of FLASH Versus Conventional Radiotherapy for Patients with Localized Carcinomas

By /

IntraOp Medical Corporation announced the world’s first Phase II Electron FLASH Trial.

Scroll to Top